Table of Contents
Angiotensin Receptor Blockers (ARBs) are a class of medications commonly prescribed to treat hypertension and heart failure. While effective, they require careful monitoring to ensure patient safety and optimal therapeutic outcomes. Healthcare providers must be aware of key parameters to monitor during ARB therapy.
Baseline Assessments Before Initiating ARBs
- Blood pressure measurement
- Serum electrolytes, especially potassium levels
- Renal function tests, including serum creatinine and estimated glomerular filtration rate (eGFR)
- History of angioedema or hypersensitivity reactions
Monitoring Parameters During Therapy
Blood Pressure
Regular monitoring of blood pressure helps assess the effectiveness of ARB therapy and guides dose adjustments. It is recommended to check blood pressure at each clinical visit.
Serum Electrolytes
Potassium levels should be monitored periodically, especially in patients with renal impairment or those on other medications affecting potassium balance. Hyperkalemia is a potential adverse effect of ARBs.
Renal Function
Serum creatinine and eGFR should be checked regularly. An increase in serum creatinine of more than 30% from baseline warrants reevaluation of therapy, as ARBs can affect renal function.
Adverse Effects and Safety Precautions
Patients on ARBs should be monitored for signs of adverse effects such as hypotension, hyperkalemia, and renal impairment. Patients should be instructed to report symptoms like dizziness, muscle weakness, or decreased urine output promptly.
Special Considerations
- Patients with bilateral renal artery stenosis require careful monitoring due to increased risk of renal failure.
- Pregnant women should avoid ARBs because of potential harm to the fetus.
- Adjustments may be necessary in patients with concomitant use of other medications affecting renal function or electrolytes.
In summary, regular monitoring of blood pressure, serum electrolytes, and renal function is essential for safe and effective use of ARBs. Tailoring the monitoring schedule to individual patient risk factors enhances treatment outcomes and minimizes adverse effects.